![Kathleen Rokita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Rokita
Direktor/Vorstandsmitglied bei
PREVECEUTICAL MEDICAL INC.
Vermögen: 18 000 $ am 31.05.2026
Profil
Kathleen Rokita is currently an Independent Director at PreveCeutical Medical, Inc. since 2022 and a Principal at Somerset CPAs PC.
Former roles include Director at St. Vincent Hospital Foundation and Treasurer & Director at Angelman Syndrome Foundation, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.09.2025 | 2 000 000 ( 0,33 % ) | 18 000 $ | 31.05.2026 |
Aktive Positionen von Kathleen Rokita
| Unternehmen | Position | Beginn |
|---|---|---|
| PREVECEUTICAL MEDICAL INC. | Direktor/Vorstandsmitglied | 19.10.2022 |
Somerset CPAs PC
 Somerset CPAs PC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kathleen Rokita
| Unternehmen | Position | Ende |
|---|---|---|
Angelman Syndrome Foundation, Inc.
 Angelman Syndrome Foundation, Inc. Angelman Syndrome Foundation, Inc. is a nonprofit organization dedicated to advancing awareness, education, research, treatment, and support for individuals affected by Angelman syndrome, a rare neurogenetic disorder caused by loss of function of the maternal UBE3A gene. The non-profit company is based in Aurora, IL. The foundation funds research projects focused on understanding Angelman syndrome, improving clinical care, and developing potential treatments, including gene therapy, CRISPR gene editing, and clinical trials of emerging therapies. It operates a network of specialized multidisciplinary clinics, maintains the Angelman syndrome registry, and supports research collaborations. The foundation provides educational resources, family support programs, advocacy, and community engagement opportunities. | Direktor/Vorstandsmitglied | - |
St. Vincent Hospital Foundation | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Somerset CPAs PC
Somerset CPAs PC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
St. Vincent Hospital Foundation | |
Angelman Syndrome Foundation, Inc.
Angelman Syndrome Foundation, Inc. Angelman Syndrome Foundation, Inc. is a nonprofit organization dedicated to advancing awareness, education, research, treatment, and support for individuals affected by Angelman syndrome, a rare neurogenetic disorder caused by loss of function of the maternal UBE3A gene. The non-profit company is based in Aurora, IL. The foundation funds research projects focused on understanding Angelman syndrome, improving clinical care, and developing potential treatments, including gene therapy, CRISPR gene editing, and clinical trials of emerging therapies. It operates a network of specialized multidisciplinary clinics, maintains the Angelman syndrome registry, and supports research collaborations. The foundation provides educational resources, family support programs, advocacy, and community engagement opportunities. | |
PreveCeutical Medical, Inc.
 PreveCeutical Medical, Inc. Pharmaceuticals: MajorHealth Technology Provides preventive health products and services | Health Technology |
